Clinical relevance of ion channels for diagnosis and therapy of cancer

被引:96
作者
Schönherr, R [1 ]
机构
[1] Univ Jena, Fac Med, Res Unit Mol & Cellular Biophys, D-07747 Jena, Germany
关键词
ion channels; cancer; therapeutic target; prognostic marker;
D O I
10.1007/s00232-005-0782-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ion channels have a critical role in cell proliferation and it is well documented that channel blockers can inhibit the growth of cancer cells. The concept of ion channels as therapeutic targets or prognostic biomarkers attracts increasing interest, but the lack of potent and selective channel modulators has hampered a critical verification for many years. Today, the knowledge of human ion channel genes is almost complete and molecular correlates for many native currents have already been identified. This information triggered a wave of experimental results, identifying individual ion channels with relevance for specific cancer types. The current pattern of cancer-related ion channels is not arbitrary, but can be reduced to few members from each ion channel family. This review aims to provide an overview of the molecularly identified ion channels that might be relevant for the most common human cancer types. Possible applications of these candidates for a targeted cancer therapy or for clinical diagnosis are discussed.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 69 条
[11]   International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: Transient receptor potential channels [J].
Clapham, DE ;
Montell, C ;
Schultz, G ;
Julius, D .
PHARMACOLOGICAL REVIEWS, 2003, 55 (04) :591-596
[12]  
De Ponti F, 2002, DRUG SAFETY, V25, P263
[13]   Inverse association between prostate cancer and the use of calcium channel blockers [J].
Debes, JD ;
Roberts, RO ;
Jacobson, DJ ;
Girman, CJ ;
Lieber, MM ;
Tindall, DJ ;
Jacobsen, SJ .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) :255-259
[14]   Expression profiles of voltage-gated Na+ channel α-subunit genes in rat and human prostate cancer cell lines [J].
Diss, JKJ ;
Archer, SN ;
Hirano, J ;
Fraser, SP ;
Djamgoz, MBA .
PROSTATE, 2001, 48 (03) :165-178
[15]   Molecular pharmacology of high voltage-activated calcium channels [J].
Doering, CJ ;
Zamponi, GW .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2003, 35 (06) :491-505
[16]  
Duncan LM, 1998, CANCER RES, V58, P1515
[17]   Melastatin expression and prognosis in cutaneous malignant melanoma [J].
Duncan, LM ;
Deeds, J ;
Cronin, FE ;
Donovan, M ;
Sober, AJ ;
Kauffman, M ;
McCarty, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :568-576
[18]   Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium [J].
Elble, RC ;
Pauli, BU .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :40510-40517
[19]   Ether a go-go potassium channels as human cervical cancer markers [J].
Farias, LMB ;
Ocaña, DB ;
Díaz, L ;
Larrea, F ;
Avila-Chávez, E ;
Cadena, A ;
Hinojosa, LM ;
Lara, G ;
Villanueva, LA ;
Vargas, C ;
Hernández-Gallegos, E ;
Camacho-Arroyo, I ;
Dueñas-González, A ;
Pérez-Cárdenas, E ;
Pardo, LA ;
Morales, A ;
Taja-Chayeb, L ;
Escamilla, J ;
Sánchez-Peña, C ;
Camacho, J .
CANCER RESEARCH, 2004, 64 (19) :6996-7001
[20]   Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer:: a novel prognostic marker for tumor progression [J].
Fixemer, T ;
Wissenbach, U ;
Flockerzi, V ;
Bonkhoff, H .
ONCOGENE, 2003, 22 (49) :7858-7861